Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll‐like receptor 4
Samantha Milanesi, Daniela Verzola, Francesca Cappadona, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 10868-10876
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 220
Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury
Hayder M. Al‐kuraishy, MarwaS Al-Naimi, HudaA Rasheed, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2019) Vol. 10, Iss. 3, pp. 95-95
Open Access | Times Cited: 121
Renin-angiotensin system and inflammation update
Elena Cantero‐Navarro, Beatriz Fernández‐Fernández, Adrián M. Ramos, et al.
Molecular and Cellular Endocrinology (2021) Vol. 529, pp. 111254-111254
Closed Access | Times Cited: 78
Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Chenxi Lu, Huadong Zhao, Yanqing Liu, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 2, pp. 484-501
Open Access | Times Cited: 63
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, et al.
Molecular Metabolism (2022) Vol. 64, pp. 101549-101549
Open Access | Times Cited: 53
Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease
Waleed Hassan, Prabin Shrestha, Keiichi Sumida, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2215878-e2215878
Open Access | Times Cited: 44
The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications
Delun Li, Siyu Yuan, Yiyao Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation
Alessandro Maloberti, Alessandro Mengozzi, Elisa Russo, et al.
High Blood Pressure & Cardiovascular Prevention (2023) Vol. 30, Iss. 5, pp. 411-425
Open Access | Times Cited: 37
Uric acid in CKD: has the jury come to the verdict?
Barbara Bonino, Giovanna Leoncini, Elisa Russo, et al.
Journal of Nephrology (2020) Vol. 33, Iss. 4, pp. 715-724
Closed Access | Times Cited: 55
Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Structural analysis and attenuates hyperuricemic nephropathy of dextran from the Imperata cylindrica Beauv. var. major (Nees) C. E. Hubb.
Wenchen Yu, Yi Xiong, Mengnan Liu, et al.
Carbohydrate Polymers (2023) Vol. 317, pp. 121064-121064
Closed Access | Times Cited: 19
Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
Elisa Russo, Giovanna Leoncini, Pasquale Esposito, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4479-4479
Open Access | Times Cited: 49
Immunomodulatory mechanism of a purified polysaccharide isolated from Isaria cicadae Miquel on RAW264.7 cells via activating TLR4-MAPK-NF-κB signaling pathway
Zhanchi Xu, Ruyi Lin, Xuenan Hou, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 4329-4338
Closed Access | Times Cited: 48
Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies
Arrigo F.G. Cicero, Roberto Pontremoli, Federica Fogacci, et al.
Drug Safety (2020) Vol. 43, Iss. 8, pp. 727-736
Closed Access | Times Cited: 41
The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor
Kaiyue Li, Kongwei Li, Qingmei Yao, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16097-e16097
Open Access | Times Cited: 14
Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy
Huilong Xiang, Huan Lei, Ziyuan Liu, et al.
Toxicology and Applied Pharmacology (2021) Vol. 424, pp. 115594-115594
Closed Access | Times Cited: 32
Inflammatory Response and Oxidative Stress as Mechanism of Reducing Hyperuricemia of Gardenia jasminoides‐Poria cocos with Network Pharmacology
Lijun Liu, Shengjun Jiang, Xuqiang Liu, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 30
Chemical Characterization and Immunomodulatory Activity of Fucoidan from Sargassum hemiphyllum
Rui Li, Qingling Zhou, Shutong Chen, et al.
Marine Drugs (2022) Vol. 21, Iss. 1, pp. 18-18
Open Access | Times Cited: 22
Cellular mechanisms and molecular pathways linking bitter taste receptor signalling to cardiac inflammation, oxidative stress, arrhythmia and contractile dysfunction in heart diseases
Menizibeya O. Welcome, D Dogo, Nikos E. Mastorakis
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 89-117
Open Access | Times Cited: 19
Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs
Elisa Russo, Maria Bertolotto, Valentina Zanetti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2960-2960
Open Access | Times Cited: 12
Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia‐related chronic kidney disease
Jing Liu, Fan Guo, Xiaoting Chen, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 4
Uric acid and atherosclerosis in patients with chronic kidney disease: recent, progress, mechanisms and prospect.
Ye Liu, Zeyu Li, Yuanwen Xu, et al.
Kidney Diseases (2025) Vol. 11, Iss. 1, pp. 112-127
Open Access
Metabolic crosstalk and therapeutic interplay between diabetes and hyperuricemia
Tianshu Yang, Lingyun Luo, Xuelian Luo, et al.
Diabetes Research and Clinical Practice (2025), pp. 112204-112204
Open Access
Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
Elisa Russo, Elisabetta Bussalino, Lucia Macciò, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9422-9422
Open Access | Times Cited: 9
Therapeutic effects of traditional Chinese medicine on gouty nephropathy: Based on NF-κB signalingpathways
Peng Liu, Guijie Ma, Yang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114199-114199
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top